rcd1 dog model of retinitis pigmentosa: NT-501 implant protected outer nuclear layer from photoreceptor loss
“An early pharmacology study showed that the outer nuclear layer (ONL) in dogs with retinitis pigmentosa caused by rod-cone dysplasia type 1 (rcd1) was protected from photoreceptor loss following implantation of NT-501.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Why that model
Rcd1 dogs are a well-established animal model for retinitis pigmentosa
“Rcd1 dogs are a well-established animal model for retinitis pigmentosa.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Reviewer's view of the efficacy data
rcd1 dog study preliminary: used early 11 mm prototype vs 6.5 mm clinical device
“The device used in this study is an early prototype that is 11 mm in length (the proposed clinical device is 6.5 mm). Thus, this study is preliminary regarding assessing the overall pharmacology of the product, NT-501.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
autologous cultured chondrocytes on porcine collagen membrane · Autologous chondrocytes
Analogous MACI (animal cells on same membrane) in critical-sized knee/stifle cartilage defects in rabbits and horses: improved repair vs membrane alone or empty defect